Switching from trivalent to quadrivalent inactivated influenza vaccines in Uruguay: a cost-effectiveness analysis

• Auteurs principaux: Pablo Manuel Bianculli (Auteur), Lucile Bellier (Auteur), Ignacio Olivera Mangado (Auteur), Carlos Grau Pérez (Auteur), Gustavo Mieres (Auteur), Luis Lazarov (Auteur), Audrey Petitjean (Auteur), Hugo Dibarboure (Auteur), Juan Guillermo Lopez (Auteur)
• Format: Livre
• Publié: Taylor & Francis Group, 2022-11-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

We evaluated the cost-utility of replacing trivalent influenza vaccine (TIV) with quadrivalent influenza vaccine (QIV) in the current target populations in Uruguay. An existing decision-analytic static cost-effectiveness model was adapted for Uruguay. The population was stratified into age groups. C...